What is hearX?
hearX Group operates as a sophisticated medtech scale-up, distinguished by its dual-pronged business model that addresses both professional clinical needs and direct-to-consumer accessibility. Through its B2B division, the company provides innovative diagnostic tools for hearing healthcare professionals, while its B2C arm, Lexie Hearing, disrupts the market with over-the-counter hearing aids integrated into a comprehensive remote care ecosystem. By utilizing artificial intelligence and big data, hearX has effectively lowered the barrier to entry for hearing loss treatment, implementing a unique behavior-change rewards program that enhances patient outcomes and reduces product return rates. This strategic integration of smart technology and clinical expertise positions hearX as a leader in the digital health sector, specifically within the hearing loss intervention market.
How much funding has hearX raised?
hearX has raised a total of $3.8M across 1 funding round:
Series A
$3.8M
Series A (2021): $3.8M with participation from Sphere Holdings, Bose Ventures, Futuregrowth, and Havac
Key Investors in hearX
Sphere Holdings
A diversified investment holding company focused on long-term value creation through strategic partnerships in emerging markets.
Bose Ventures
The corporate venture capital arm of Bose Corporation, specializing in early-stage investments within the audio technology and health-tech sectors.
Futuregrowth
A prominent asset manager with a strong focus on developmental and impact investing across various high-growth industries.
What's next for hearX?
With the recent capital injection, hearX is poised to scale its operations significantly, focusing on the refinement of its AI-driven diagnostic suite and the broader adoption of the Lexie Hearing platform. The company's roadmap likely involves deepening its penetration into international markets where hearing health accessibility remains a critical challenge. By maintaining its focus on cost-effective, remote-care models, hearX is set to capitalize on the growing demand for decentralized healthcare services. Future growth will likely be driven by continued investment in R&D to enhance the efficacy of its OTC hearing aids and the expansion of its B2B clinical partnerships, ensuring that the firm remains at the forefront of the global hearing health revolution.
See full hearX company page
